CK14+17+42+10, PE-Cy7 conjugated
CK14+17+42+10, PE-Cy7 conjugated is a PE/Cy7 conjugated antibody targeting KRT14. This antibody is suitable for IF. It exhibits reactivity with Human, Mouse samples.
Product Specifications
Product Name Alternative
Cytokeratin 14; CK 14; ck14; Cytokeratin14; Cytokeratin-14; Dowling Meara; ebs3; Epidermolysis bullosa simplex; k14; Keratin 14; Keratin type I cytoskeletal 14; Keratin14; Koebner; Krt 14; krt14; EBS3; EBS4; NFJ; Keratin, type I cytoskeletal 14; Cytokeratin 17; CK 17; ck17; Cytokeratin17; Cytokeratin-17; Keratin, type I cytoskeletal 17; Cytokeratin 10; CK 10; ck10; Cytokeratin10; Cytokeratin-10; Keratin, type I cytoskeletal 10; Cytokeratin 42; CK 42; ck42; Cytokeratin42; Cytokeratin-42; Keratin, type I cytoskeletal 42; K1C14_HUMAN.
Reactivity
Human, Mouse
Target
KRT14
Conjugation
PE/Cy7
Dilution
IF=1:100-500
Notes
For research use only.
Prediction Reactivity
Rat
Tested Applications
IF
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940096-100 1x 100 µL
Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880096-500 1x 500 µL
Histone H1 (AE-4), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 